Showing 1 posts of 1 posts found.
Lonza and Engitix have entered into a licensing agreement to support the development of antibody-drug conjugates (ADCs), combining Engitix’s extracellular …
Hot-tub therapy tested as potential treatment for peripheral artery disease
Raimond takes helm at Nuclera
Most advanced breast cancer patients treated in community settings, Phesi study finds
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison
Bramacare opens supported-living facility for eating disorder recovery